<DOC>
	<DOC>NCT02629003</DOC>
	<brief_summary>The purpose of this study is to determine the dosimetry for the Positron Emission Tomography (PET) tracer [11C]Cimbi-36 in two different Carbon-11 labelling positions. This information will contribute to determining whether [11C]Cimbi-36 can be optimized by changing the C-11 labelling position.</brief_summary>
	<brief_title>[11C]Cimbi-36 Dosimetry</brief_title>
	<detailed_description>Healthy subjects wil undergo a whole-body Positron Emission Tomography (PET) scan with the Serotonin 2A Receptor (5-HT2A) radioligand [11C]Cimbi-36 or [11C]Cimbi-36-5 to determine the effective radiation dose and radiation dose for selected organs.</detailed_description>
	<criteria>18 years of age Signed informed consent Present or former neurological disease, severe somatic or psychiatric disease, or medication thet can interfere with the test results. Pregnancy at the time of the scan Breastfeeding Alcohol or substance abuse Exposure to radiation (&gt;10 millisievert (mSv)) within the last year, or significant exposure at work Allergy to any of the substances in the Investigational medicinal product (IMP) formulation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Positron Emission Tomography</keyword>
	<keyword>Serotonin</keyword>
	<keyword>5-HT2A</keyword>
	<keyword>Radioligand</keyword>
	<keyword>Radiation dosimetry</keyword>
	<keyword>Radiation dosage</keyword>
</DOC>